Thiopurine S-methyltransferase alleles, TPMT*2, *3B and *3C, and genotype frequencies in an Indian population

Murugesan, Raju and Saadi, Abdul Vahab and Patra, Satyajit and Rao, Rekha and Rao, Jyothi and Rai, Padmalatha S and Gopinath, PM and Satyamoorthy, K (2010) Thiopurine S-methyltransferase alleles, TPMT*2, *3B and *3C, and genotype frequencies in an Indian population. Experimental and Therapeutic Medicine, 1 (1). pp. 121-127.

[img] PDF
4._Saadi_TPMT_paper.pdf - Published Version
Restricted to Registered users only

Download (366kB) | Request a copy


Thiopurine S-methyltransferase (TPMT) catalyzes the S-methylation of aromatic and heterocyclic sulfhydryl compounds including thiopurine drugs such as 6-mercapto-purine, 6-thioguanine and azathioprine. TPMT activity exhibits genetic variation and shows tri-modal distribution with 89-94% of individuals possessing high activity, 6-11% intermediate activity and approximately 0.3% low activity. Patients with intermediate or deficient TPMT activity exposed to thiopurine drugs show severe hematopoietic toxicity. Three single nucleotide polymorphisms (SNPs) in TPMT (NM_000367.2:c.238G>C, NM_000367.2:c.460G>A and NM_000367.2:c.719A>G) define the most prevalent mutant alleles associated with loss of catalytic activity reported in several populations. The present study investigated, for the first time, the frequency distribution of these three SNPs of TPMT, their alleles and genotypes in a Southern Indian population. Peripheral blood was obtained from 326 individuals of a Southern Indian population, and genomic DNA was isolated from total peripheral white blood cells. The genotypes at the polymorphic loci were determined by allele-specific polymerase chain reaction, restriction fragment length polymorphism and confirmatory DNA sequencing. The estimated genotype frequency for homozygous TPMT*1/*1 was 97.24%, for heterozygous TPMT*1/*2 and TPMT*1/*3B, 0.61% each, and for heterozygous TPMT*1/*3C, 1.53%. The frequency of heterozygous mutants in the studied Indian population was 2.76%. This study demonstrated significant variations in TPMT gene polymorphisms in an Indian population in relation to other human populations and may help to predict both clinical efficacy and drug toxicity of thiopurine drugs.

Item Type: Article
Uncontrolled Keywords: Thiopurine S-methyltransferase, polymorphisms, Indian population, pharmacogenetics, mercaptopurine, azathioprine, genetic testing
Subjects: Life Sciences > MLSC Manipal
Depositing User: KMC Manipal
Date Deposited: 02 Jun 2012 04:39
Last Modified: 07 Nov 2016 10:54

Actions (login required)

View Item View Item